Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jump Into Tomorrow (JIT) is a Berlin-based healthcare company dedicated to longevity and preventative medicine. The company provides "Longevity as a Service," offering clients access to advanced diagnostic tools such as whole-body MRI scans, comprehensive blood panels, and epigenetic biological age testing. By integrating these high-resolution health data points, JIT creates personalized health optimization protocols designed to extend the healthy human lifespan. The company's approach focuses on the early detection of age-related diseases, including cancer and cardiovascular issues, before symptoms appear. JIT operates as a technology-driven platform that bridges the gap between traditional reactive medicine and proactive, data-led wellness management. Founded by Dr. Emil Kendziorra, the company is a key player in the emerging European longevity ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jump Into Tomorrow.